Invasive Pneumococcal Disease (IPD) (DBCOND0040168)

Identifiers

Synonyms

Pneumococcal Disease, Invasive / Invasive Pneumococcal Disease / Invasive Pneumococcal Diseases / Invasive Streptococcus pneumoniae disease (disorder)

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT05934890	A Phase 3 Study to Evaluate the Immunogenicity and Safety of Walvax's PCV13-TT as Compared to Pfizer's PCV13	No drug interventions	prevention	3	active_not_recruiting
NCT00617760	Safety and Immunogenicity Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®)	Clostridium tetani toxoid antigen (formaldehyde inactivated) Corynebacterium diphtheriae CRM197 protein Meningococcal polysaccharide vaccine group C	prevention	3	completed
NCT01083459	Impact of PCV on Disease and Colonization Among Native American Communities	No drug interventions	Not Available	Not Available	completed
NCT00885625	7-valent Pneumococcal Conjugated Vaccination	No drug interventions	prevention	4	unknown_status
NCT00371878	Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV Infection	Streptococcus pneumoniae type 14 capsular polysaccharide diphtheria CRM197 protein conjugate antigen Streptococcus pneumoniae type 18C capsular polysaccharide diphtheria CRM197 protein conjugate antigen Streptococcus pneumoniae type 19F capsular polysaccharide diphtheria CRM197 protein conjugate antigen Streptococcus pneumoniae type 23F capsular polysaccharide diphtheria CRM197 protein conjugate antigen Streptococcus pneumoniae type 4 capsular polysaccharide diphtheria CRM197 protein conjugate antigen Streptococcus pneumoniae type 6B capsular polysaccharide diphtheria CRM197 protein conjugate antigen Streptococcus pneumoniae type 9V capsular polysaccharide diphtheria CRM197 protein conjugate antigen	prevention	4	completed
NCT00227188	Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.	Streptococcus pneumoniae type 14 capsular polysaccharide diphtheria CRM197 protein conjugate antigen Streptococcus pneumoniae type 18C capsular polysaccharide diphtheria CRM197 protein conjugate antigen Streptococcus pneumoniae type 19F capsular polysaccharide diphtheria CRM197 protein conjugate antigen Streptococcus pneumoniae type 23F capsular polysaccharide diphtheria CRM197 protein conjugate antigen Streptococcus pneumoniae type 4 capsular polysaccharide diphtheria CRM197 protein conjugate antigen Streptococcus pneumoniae type 6B capsular polysaccharide diphtheria CRM197 protein conjugate antigen Streptococcus pneumoniae type 9V capsular polysaccharide diphtheria CRM197 protein conjugate antigen	Not Available	Not Available	completed
NCT00853749	Immune Response In Children Revaccinated With Pneumococcal Conjugate Vaccine	No drug interventions	other	3	completed
NCT01128439	Study Estimating the Impact of Prevnar 13™ (13vPnC) on Invasive Pneumococcal Disease	No drug interventions	Not Available	Not Available	completed
NCT04464291	An Epidemiological Survey to Establish the Spectrum of Circulating Serotypes of S. Pneumoniae, in Patients Older 18 Years	No drug interventions	screening	Not Available	completed